Back
Lucid Diagnostics 10K Form
Sell
46
LUCD
Lucid Diagnostics
Last Price:
$1.40
Seasonality Move:
-22.4%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive LUCD News And Ratings
See the #1 stock for the next 7 days that we like better than LUCD
LUCD Financial Statistics
Sales & Book Value
| Annual Sales: | $2.4M |
|---|---|
| Cash Flow: | $-10.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.96 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -1.13000 |
|---|---|
| Net Income (TTM): | $-44.8M |
| Gross Margin: | $-3.6M |
| Return on Equity: | -650.37% |
| Return on Assets: | -150.12% |
Lucid Diagnostics Earnings Forecast
Key Lucid Diagnostics Financial Ratios
-
The Gross Profit Margin over the past 4 years for LUCD is -146.25%.
-
The Selling, General & Administrative Expenses for LUCD have been equal to 1,468.62% of Gross Profit Margin.
-
The Research & Development expenses have been 298.68% of Revenue.
-
The Net Earning history of LUCD is -2,169.11% of Total Revenues.
-
Per Share Earnings over the last 5 years have been positive in 1 years.
Lucid Diagnostics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | LUCD |
| Website: | luciddx.com |
Debt
| Debt-to-Equity Ratio: | 1.61 |
|---|---|
| Current Ratio: | 1.18 |
| Quick Ratio: | 1.02 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
LUCD Technical Analysis vs Fundamental Analysis
Sell
46
Lucid Diagnostics (LUCD)
is a Sell
Is Lucid Diagnostics a Buy or a Sell?
-
Lucid Diagnostics stock is rated a SellThe current Lucid Diagnostics [LUCD] share price is $1.39. The Score for LUCD is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.